Where evidence meets experience .

Reach more participants, generate high-quality data, and simplify clinical trials, with a unified, easy-to-use platform.

One platform, from start to finish.

Onboard your participants

Total Consent Management incorporates easy-to-use tools like TeleVisit, remote scheduling, and compliant wet and dry signature to get your study started quickly and smoothly.

Take control of your trial

Keep your study on track and generate high-quality evidence with robust features like remote data collection, study notifications, participant reminders, and real-time reporting.

Data reporting and visualization

Oversight of your study data at your fingertips.

The Medable Effect


ROI for Phase III trials*


Rated DCT platform

14 of 20

Top Pharma customers

What makes us different

Medable platform morning dose diary

Best-in-class user experience

Informed by DCT experts, patient insights, and site feedback, the Medable platform accommodates the complex research landscape in an intuitive and simple user interface.

Designed to scale

Offered in over 60 countries and 120 languages, our cloud-agnostic, single API platform offers self-service build and a library of system integrations for maximum reach and scalability.

Medable worldwide map
Medable site data collection dashboard

Extensive DCT  network

Your study benefits from our extensive network of partners from retail pharmacy and site networks, data providers for RWE and LTFU, and direct-to-patient offering of connected sensors and home health providers.

Trusted by

The latest from Medable


Demo On Demand: eCOA+, patient & site experiences, and pulse oximeter sensor

6 min

VP of Solution Consulting, Jess Dolphi, showcases a few of the platform’s features, including site experience, patient experience, data and oversight dashboards, and a demonstration of connecting a pulse oximeter sensor for remote data capture.

White Papers, Case Studies, Reports

U.S. Renal Care achieves 75% site adoption of eConsent with Medable

Medable’s Total Consent, used by U.S. Renal Care in top ten pharma-sponsored study, proved to be a flexible, fast, and efficient solution for the elderly renal care population.


Ethical Review of Decentralized Clinical Trials (DCTs): Tools, Resources & Best Practices

6 min

Industry experts from Medable and Harvard School of Medicine discuss how to equip your future digital/decentralized trial IRB & ethics submissions for success.

Prix Galien Best Digital Health Solution - Medable

Medable Wins 2024 Prix Galien UK Award for Best Digital Health Solution

6 min

Medable today announced that its evidence generation platform was awarded “Best Digital Health Solution” from a field of 17 nominees at the Prix Galien UK Forum in London. This marks the second time Medable has won the Best Digital Health Solution award, first taking home the honor in 2023 at the Prix Galien US ceremony. 

Tufts CSDD

New Research from Partnership for Advancing Clinical Trials (PACT) Reveals Decentralized Clinical Trials (DCTs) Beat Timeline Expectations

6 min

Medable today announced that the Partnership for Advancing Clinical Trials (PACT) consortium in conjunction with the Tufts Center for the Study of Drug Development (CSDD) has produced compelling results from a new study.

Elderly Patients in US Renal Care Trial using Total Consent

Medable Achieves 75% eConsent Adoption Across Elderly Patients in Pivotal U.S. Renal Care Clinical Trial

6 min

The Phase IV trial, funded by a top-10 global pharmaceutical company, had a narrow recruitment window to enroll patients suffering from Anemia in End Stage Kidney Disease (ESKD) across more than 40 dialysis centers, involving 476 site users.

See how Medable can make your trials more efficient.